Product Images Rebyota
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Rebyota NDC 55566-9800 by Ferring Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - rebyota 01
The text is a description of a medical administration kit with an administration tube spike, administration set, and a bag containing REBYOTA. The bag is sealed and opaque, and should be thawed before use. There is a pinch and clamp featured on the spike. A disposable underpad is not included, along with a water-soluble lubricant.*
Figure 2 - rebyota 02
Figure 3 - rebyota 03
The text is describing an image labeled as "Figure 3". It appears to show a spike port labeled as "iml" along with a 2z Tex() labeled as "01 1" for administration. A bag containing a thawed REBYOTAin is also visible, along with a tube spike. The bag is described as being sealed and opaque.*
Figure 4 and Figure 5 - rebyota 04
The text provides instructions for two lying positions: resting on the left side with a bent knee and comfortable arms, and assuming a knee-chest position with the left side of the face resting on the surface and the left arm folded comfortably. No additional information is available.*
Figure 6 - rebyota 05
This text provides instructions for inserting a medical device into the rectum. Specifically, it suggests inserting about 12 centimeters (5 inches) into the rectum. There is no additional information available to provide the context or purpose for this procedure.*
Figure 7 and Figure 8 - rebyota 06
Figure 9 and Figure 10 - rebyota 07
PRINCIPAL DISPLAY PANEL - 150 mL Bag Carton - rebyota 08
REBYOTA is a medication used for rectal administration to alter the gut microbiota in patients. It is made up of live microorganisms sourced from qualified human fecal donors and contains a defined amount of polyethylene glycol 2350 in saline as an excipient. This drug must be stored in an ultra-cold freezer at -60°C to -90°C, and once opened, the content should be used with an Administration Set provided in a separate carton. It is produced by Rebiotix, Inc. and manufactured for Ferring Pharmaceuticals in the United States. This information is not intended to be comprehensive; for dosage information and more, see the enclosed prescribing information.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.